Bavarian Nordic

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing, and commercialization of life-saving vaccines. Bavarian Nordic is a global leader in smallpox vaccines and has been a long-term supplier to the U.S. government of a non-replicating smallpox vaccine, which has been approved by the U.S. Food and Drug Administration (FDA) and is also approved for the prevention of monkeypox. The vaccine is approved for use against smallpox in Europe and Canada. Bavarian Nordic's commercial portfolio also includes market-leading rabies and tick-borne encephalitis vaccines. Leveraging its MVA-BN live virus vaccine platform technology, Bavarian Nordic has created a diverse portfolio of proprietary and partnered product candidates aimed at saving and improving lives by harnessing the power of the immune system, including an Ebola vaccine licensed to Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.